John Lagergren, a staff scientist in Oak Ridge National Laboratory’s Plant Systems Biology group, is using his expertise in applied math and machine learning to develop neural networks to quickly analyze the vast amounts of data on plant traits amassed at ORNL’s Advanced Plant Phenotyping Laboratory.
Howard Wilson explores how to accelerate the delivery of fusion energy as Fusion Pilot Plant R&D lead at ORNL. Wilson envisions a fusion hub with ORNL at the center, bringing together the lab's unique expertise and capabilities with domestic and international partnerships to realize the potential of fusion energy.
Ilenne Del Valle is merging her expertise in synthetic biology and environmental science to develop new technologies to help scientists better understand and engineer ecosystems for climate resilience.
When virtually unlimited energy from fusion becomes a reality on Earth, Phil Snyder and his team will have had a hand in making it happen.
Carrie Eckert applies her skills as a synthetic biologist at ORNL to turn microorganisms into tiny factories that produce a variety of valuable fuels, chemicals and materials for the growing bioeconomy.
As a metabolic engineer at Oak Ridge National Laboratory, Adam Guss modifies microbes to perform the diverse processes needed to make sustainable biofuels and bioproducts.
From the helm of a one-of-a-kind organization that brings nuclear fusion and fission expertise together to pave the way to expanding carbon-free energy, Kathy McCarthy can trace the first step of her engineering career back to
Chuck Kessel was still in high school when he saw a scientist hold up a tiny vial of water and say, “This could fuel a house for a whole year.”
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.